MicroRNA-107 functions as a candidate tumor suppressor gene in renal clear cell carcinoma involving multiple genes

Urologic Oncology: Seminars and Original Investigations

Volumn 33, Issue 5, 2015, Pages 205.e1-205.e11

  Song, Nan ^a   Ma, Xin ^a   Li, Hongzhao ^a   Zhang, Yu ^a   Wang, Xiaoxiong ^a   Zhou, Pingkun ^b   Zhang, Xu ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

EIF5; MicroRNA; miR 107; p53; Renal cell carcinoma; VHL

Indexed keywords

INITIATION FACTOR 5; LENTIVIRUS VECTOR; MICRORNA 107; PROTEIN P53; MICRORNA; MIRN197 MICRORNA, HUMAN;

ADULT; ARTICLE; BIOSYNTHESIS; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CLEAR CELL CARCINOMA; CLINICAL FEATURE; EUKARYOTE; FEMALE; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY TUMOR; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL CELL CARCINOMA CELL LINE; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; ANIMAL; CELL GROWTH; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; MOUSE; NUDE MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; CARCINOMA, RENAL CELL; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; KIDNEY NEOPLASMS; MALE; MICE; MICE, NUDE; MICRORNAS; MIDDLE AGED; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84929262086     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2015.02.003     Document Type: Article

References (30)

1. Siegel R., Ma J., Zou Z., Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014, 64:9-29.
2. Shahzad H. Expression of Von Hippel-Lindau (VHL) gene mutation in diagnosed cases of renal cell carcinoma. Pak J Med Sci 2014, 30:880-885.
3. McCright B. Notch signaling in kidney development. Curr Opin Nephrol Hypertens 2003, 12:5-10.
4. Hodorova I., Solar P., Mihalik J., Vecanova J., Adamkov M., Rybarova S. Investigation of tumour suppressor protein p53 in renal cell carcinoma patients. Biomed Pap Med Fac Univ Palacky Olomouc 2014, 158:44-49.
5. Linehan W.M., Rathmell W.K. Kidney cancer. Urol Oncol 2012, 30:948-951.
6. Bohlig L., Friedrich M., Engeland K. p53 activates the PANK1/miRNA-107 gene leading to downregulation of CDK6 and p130 cell cycle proteins. Nucleic Acids Res 2011, 39:440-453.
7. Wilfred Bernard R., Wang Wang-Xia, Nelson Peter T. Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways. Mol Genet Metab 2007, 91:209-217.
8. Wang W.X., Wilfred B.R., Madathil S.K., Tang G., Hu Y., Dimayuga J., et al. miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease. Am J Pathol 2010, 177:334-345.
9. Paraskevi A., Theodoropoulos G., Papaconstantinou I., Mantzaris G., Nikiteas N., Gazouli M. Circulating MicroRNA in inflammatory bowel disease. J Crohn's Colitis 2012, 6:900-904.
10. Xiao-Yu Li, Luo Q-F, Wei Chuan-Kui, Li Deng-Feng, Li Jia, Fang Lin MiRNA-107 inhibits proliferation and migration by targeting CDK8 in breast cancer. Int J Clin Exp Med 2014, 7:32-40.
11. Tu H.F., Lin S.C., Chang K.W. MicroRNA aberrances in head and neck cancer: pathogenetic and clinical significance. Curr Opin Otolaryngol Head Neck Surg 2013, 21:104-111.
12. He J., Zhang W., Zhou Q., Zhao T., Song Y., Chai L., et al. Low-expression of microRNA-107 inhibits cell apoptosis in glioma by upregulation of SALL4. Int J Biochem Cell Biol 2013, 45:1962-1973.
13. Feng L., Xie Y., Zhang H., Wu Y. miR-107 targets cyclin-dependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cells. Med Oncol 2012, 29:856-863.
14. Yukari Takahashi, Forrest A.R., Maeno E., Hashimoto T., Daub C.O., Yasuda J. MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines. PLoS One 2009, 4:e6677.
15. Benderska N., Schneider-Stock R. Transcription control of DAPK. Apoptosis 2014, 19:298-305.
16. Li F., Liu B., Gao Y., Liu Y., Xu Y., Tong W., et al. Upregulation of microRNA-107 induces proliferation in human gastric cancer cells by targeting the transcription factor FOXO1. FEBS Lett 2014, 588:538-544.
17. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
18. Pastor F., Kolonias D., Giangrande P.H., Gilboa E. Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay. Nature 2010, 465:227-230.
19. Maiti T., Maitra U. Characterization of translation initiation factor 5 (eIF5) from Saccharomyces cerevisiae: Functional Homology With Mammalian EIF5 and the effect of depletion of EIF5 on protein synthesis in vivo andin vitro. J Biol Chem 1997, 272:18333-18340.
20. Kausik Si K.D., Umadas Maitra Characterization of multiple mRNAs that encode mammalian translation initiation factor 5 (EIF-5). J Biol Chem 1996, 271:16934-16938.
21. Cheng A.M., Byrom M.W., Shelton J., Ford L.P. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 2005, 33:1290-1297.
22. Datta J., Smith A., Lang J.C., Islam M., Dutt D., Teknos T.N., et al. microRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase Cvarepsilon. Oncogene 2012, 31:4045-4053.
23. Lujambio A., Lowe S.W. The microcosmos of cancer. Nature 2012, 482:347-355.
24. Ramaiah M.J., Pushpavalli S.N., Lavanya A., Bhadra K., Haritha V., Patel N., et al. Novel anthranilamide-pyrazolo[1,5-a]pyrimidine conjugates modulate the expression of p53-MYCN associated micro RNAs in neuroblastoma cells and cause cell cycle arrest and apoptosis. Bioorg Med Chem Lett 2013, 23:5699-5706.
25. Saito T., Saetrom P. MicroRNAs-targeting and target prediction. New Biotechnol 2010, 27:243-249.
26. Sun S., Du R., Gao J., Ning X., Xie H., Lin X., et al. Expression and clinical significance of Notch receptors in human renal cell carcinoma. Pathology 2009, 41:335-341.
27. OCP Xu GF, Viskochil D. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 1990, 62:599-608.
28. Loges S., Mazzone M., Hohensinner P., Carmeliet P. Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited. Cancer Cell 2009, 15:167-170.
29. Quivy A., Daste A., Harbaoui A., Duc S., Bernhard J.C., Gross-Goupil M., et al. Optimal management of renal cell carcinoma in the elderly: a review. Clin Interv Aging 2013, 8:433-442.
30. El-Dahr S., Hilliard S., Aboudehen K., Saifudeen Z. The MDM2-p53 pathway: multiple roles in kidney development. Pediatr Nephrol 2014, 29:621-627.